Breast cancer treatment cost and cost coping analyses. by Kekeli Kodjo Adanu (12218897)

Subjects:

All DEGs in wild-type and <i>atb’’αβγδ</i> plants. by Hyuk Sung Yoon (20208672)

Assessment of the potential cost of MAEs. by Josephine Henry Basil (19105873)

“…Moreover, factors significantly associated with moderately severe errors were intravenous medication administration, younger neonates, and an increased number of medications administered. …”

Subgroup analysis of the relationship between the rate of alert detection by an attending physician and direct cost as well as total cost. by Hai-bo Ai (20790405)

Subjects:

Differentially expressed genes (DEGs) between PMR and HC. by Xinlei Ma (1423633)

Distribution of OOP cost across illness. by Abdur Razzaque Sarker (7542854)

Cost burden across socioeconomic groups. by Abdur Razzaque Sarker (7542854)

Ethylene-related differentially expressed genes (DEGs) under 1-MCP treatment and HNT interaction effect in Antonio. by Wardah K. Mustahsan (17484456)

Lists of top 20 hub genes identified from differentially expressed genes (DEGs) between the different comparisons. by Wardah K. Mustahsan (17484456)

The Pareto chart showing the 30 most significant factors on the number of steps before a fall for the fastest speed. by Amy Mitchell (3208905)

Subjects:

The Pareto chart showing the 30 most significant factors on the number of steps before a fall for the middle speed. by Amy Mitchell (3208905)

Subjects:

Covid-19 costs per case by characteristics. by Medine Gözde Üstündağ (21011549)

Subjects:

Cost-sharing model of the supply chain. by Hong Zhang (25820)

“…The findings reveal inefficiencies in supply chain coordination under these conditions, prompting the design of a cost-sharing and profit-sharing contract model. By applying these contracts, supply chain coordination is significantly improved, leading to enhanced collaboration, optimized resource allocation, and increased profitability for all stakeholders. …”

Socio-demographic characteristics and total hospitalization cost of lung cancer. by Habib Jalilian (11328174)

Subjects:

Trend of patient contribution rate of hospitalization cost of lung cancer. by Habib Jalilian (11328174)

Subjects:

Cost-effectiveness plane: Cost-utility analysis with life-time horizon. by Emily Holmes (418302)

Subjects:

Y-27632 collaborated with BA to attenuate the increase in the integrity and decrease in the permeability of epithelial barrier injury induced by LPS in Caco2 monolayers. by Luqiong Liu (11537092)

“…<p>(<b>A)</b> Y-27632 collaborated with BA to attenuate the effect of LPS on TEER in Caco2 cells on days 1–22. (<b>B)</b> Y-27632 collaborated with BA to attenuate the effect of LPS on TEER in Caco2 cells on day 22. …”

Y-27632 synergized with BA to alleviate the decrease in the expression of and abnormal localization of ZO-1 and Occludin in LPS-induced Caco2 cells. by Luqiong Liu (11537092)

The total healthcare costs for IS. by Hee Jung Son (14285076)

“…Among surgical treatments, the proportions of corpectomy and anterior fusion declined, while proportion of incision and drainage increased (<i>P</i> < 0.05, respectively). The total healthcare costs increased 2.9-fold from $29,821,391.65 in 2010 to $86,815,775.81 in 2019 with a significant increase in the ratio to gross domestic product. …”

Simulated adoption rate by cost. by Fivita Stri (22478294)